Peptide and Protocol Glossary

Adrenocorticotropic Hormone. The pituitary signal that drives adrenal cortisol production. Measured to differentiate primary adrenal insufficiency from pituitary-driven dysfunction.

A post-translational modification in which an acetyl group is added to a protein, often to a lysine residue. Regulates gene expression, protein stability, and is the modification reversed by sirtuins.

An experimental peptidomimetic studied in animal models for selective destruction of adipose tissue blood supply. Research-only compound; not a clinical agent.

A hormone secreted by adipose tissue that improves insulin sensitivity and exerts anti-inflammatory effects. Paradoxically, levels are inversely related to body fat.

An agent added to enhance the effect of a primary compound. In protocol design, an adjuvant supports rather than drives the primary outcome.

A molecule that binds a receptor and activates it, producing a biological response. Full agonists produce maximal response; partial agonists produce less than maximal even at saturation.

The most abundant serum protein. Carries hormones, drugs, and fatty acids. Low albumin can indicate liver dysfunction, malnutrition, or chronic inflammation.

The primary mineralocorticoid hormone produced by the adrenal cortex. Regulates sodium retention and potassium excretion. Central to blood pressure and fluid balance.

A small sterile pad saturated with isopropyl alcohol used to clean the vial stopper and the injection site before each use. Standard sterile-technique consumable.

Alkaline Phosphatase. An enzyme found in liver, bone, intestine, and placenta. Elevated ALP can indicate cholestatic liver disease or active bone turnover.

Alanine Aminotransferase. A liver enzyme released into the blood when hepatocytes are damaged. The most sensitive single marker of acute liver injury on a standard panel.

AMP-activated Protein Kinase. The cellular energy sensor that activates when ATP is low, switching cells from anabolic to catabolic mode. Activated by exercise, caloric restriction, metformin, and MOTS-c.

A modified fragment of human growth hormone (residues 176-191) explored in research for its lipolytic properties without the broader systemic effects of full-length growth hormone. Sometimes called the "fat burning fragment."

Apolipoprotein A1. The primary structural protein of HDL particles. Higher Apo-A1 generally signals more functional reverse cholesterol transport capacity.

Apolipoprotein B, a protein found on every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)). One Apo-B equals one particle. Considered by many lipidologists a more accurate cardiovascular risk marker than LDL-C alone.

A small peptide derived from erythropoietin that retains tissue-protective and anti-inflammatory activity without erythropoiesis. Studied in neuropathic pain and inflammatory contexts.

Aspartate Aminotransferase. A liver enzyme also found in heart and skeletal muscle. The AST/ALT ratio carries diagnostic information about the source of injury.

Area Under the Curve. The integral of plasma concentration over time, reflecting total systemic exposure to a compound. A core pharmacokinetic measure.

The cellular process of degrading and recycling damaged organelles and misfolded proteins. Triggered by fasting, exercise, and certain compounds. A key concept in longevity research and central to mitochondrial quality control.

Sterile water containing 0.9% benzyl alcohol as a preservative. The standard reconstitution diluent for lyophilized peptides because the preservative inhibits bacterial growth across multiple-use vials. See Module 3

Lab values, body composition metrics, and subjective markers gathered before a protocol begins. Baseline is the only thing that turns response into measurable change.

Brain-Derived Neurotrophic Factor. A protein supporting neuron survival, growth, and synaptic plasticity. Frequently cited in research on Semax, Selank, and Cerebrolysin as a downstream marker of neurotrophic activity.

The mitochondrial process of breaking down fatty acid chains into acetyl coenzyme A units for energy production. Central to fat metabolism and elevated by exercise and fasting.

The angled tip of a hypodermic needle. The "bevel up" orientation is the standard injection position because it creates the smoothest tissue entry and the least mechanical disruption.

The fraction of an administered dose that reaches systemic circulation in unchanged form. Subcutaneous and intramuscular routes typically have higher bioavailability than oral for peptides.

The sum of free testosterone plus weakly albumin-bound testosterone, representing the fraction available to tissues. Often more clinically useful than total testosterone.

A sustained, low-amplitude elevation in plasma concentration produced by long-acting compounds. Contrasts with a pulse. Different goals, different trade-offs.

Body Protective Compound 157, a synthetic pentadecapeptide derived from a sequence in human gastric juice. Studied extensively in animal models for connective tissue repair, gut lining integrity, and angiogenesis. One of the most researched peptides in the recovery category.

The acetate salt form of BPC-157, the most common research-grade salt. Refers to how the peptide is paired with an acidic counterion to stabilize the lyophilized form.

A salt variant in which BPC-157 is paired with arginine. Marketed for purported solubility and stability differences relative to the acetate form. Comparative data is limited.

A melanocortin receptor agonist studied for sexual response. Acts on the central nervous system rather than peripheral vascular pathways, which distinguishes it mechanistically from PDE5 inhibitors.

A reduced-intensity protocol used between primary cycles to maintain partial benefit while still allowing some receptor recovery. A middle ground between full cycle and full washout.

Blood Urea Nitrogen. A nitrogenous waste product filtered by the kidneys. Elevated BUN can reflect impaired kidney function, dehydration, or high protein intake.

Serum calcium. Tightly regulated by parathyroid hormone, vitamin D, and calcitonin. Both deficiency and excess have systemic consequences. Should be interpreted alongside albumin (corrected calcium).

A unique phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin integrity is essential for electron transport chain function. SS-31 (Elamipretide) selectively binds cardiolipin and is the basis of mitochondrial-targeted research compounds.

A byproduct of insulin synthesis released in equal molar amounts to insulin. Distinguishes endogenous insulin production from injected insulin. Useful in diabetes subtyping.

The system by which cells receive, process, and respond to molecular messages. Encompasses receptors, second messengers, kinase cascades, and gene expression changes.

A neuropeptide preparation derived from porcine brain tissue containing low-molecular-weight peptides and free amino acids. Studied internationally in stroke recovery, traumatic brain injury, and neurodegenerative research contexts.

A growth hormone releasing hormone analog with a short half-life (approximately 30 minutes). The "no DAC" form is preferred when pulsatile GH release matching natural physiology is the goal. Commonly paired with Ipamorelin.

A long-acting variant of CJC-1295 modified with a Drug Affinity Complex that binds serum albumin, extending half-life to approximately 6 to 8 days. Produces a sustained "bleed" of GH rather than a pulse. Trade-offs differ from the no-DAC form.

The maximum plasma concentration reached after a dose. Pairs with Tmax (time to Cmax) and AUC to characterize a compound's pharmacokinetic profile.

A dosing schedule that maintains steady plasma concentration over time, typically using long-acting compounds. Contrasts with pulse dosing.

The primary glucocorticoid hormone produced by the adrenal cortex. Follows a diurnal rhythm with a morning peak. Chronically elevated cortisol blunts GH response, suppresses immune function, and disrupts sleep.

Morning serum cortisol, drawn between 7:00 and 9:00 AM. Captures the diurnal peak and is the standard screening value for adrenal function.

Late-afternoon serum cortisol, used together with AM cortisol to evaluate diurnal rhythm. Loss of the AM-to-PM gradient suggests HPA axis dysregulation.

A nitrogenous waste product of muscle metabolism filtered by the kidneys. The standard biomarker for kidney function. Elevated in renal impairment; influenced by muscle mass.

C-Reactive Protein, an acute-phase protein produced by the liver in response to inflammation. Rises within hours of an inflammatory trigger. Standard CRP is less useful for chronic, low-grade inflammation than its high-sensitivity sibling, hs-CRP.

A long-duration low-intensity dose, often used to maintain a baseline benefit between higher-amplitude cycles. Cousin to the bridge protocol.

A defined window of compound use bounded by a start date, an end date, and an intentional dosing structure. The fundamental unit of protocol design.

The deliberate construction of a cycle, including compound selection, dose, frequency, duration, washout, and outcome metrics. The discipline that distinguishes a protocol from a habit.

How often cycles repeat across a calendar year. A function of half-life, tachyphylaxis risk, and goal type.

The duration of a single cycle from first dose to last dose. Common ranges run from 4 weeks (short) to 12 weeks (extended).

The intentional practice of using a compound for a defined period followed by a defined break (washout). Done to preserve receptor sensitivity, allow physiologic recalibration, and isolate single-variable response data.

Dehydroepiandrosterone sulfate, the storage form of DHEA, a precursor adrenal steroid. Used as a marker of adrenal output and a longevity-correlated hormone that declines steadily with age.

Dihydrotestosterone. A potent androgen produced from testosterone by 5-alpha reductase. Drives androgen receptor signaling in tissues like prostate and hair follicle. Higher receptor affinity than testosterone itself.

The process by which a less specialized cell becomes more specialized in form and function. Central concept in stem cell biology and tissue regeneration.

A planned reduction of dose over time, used to ease off a compound or to test dose-response. The mirror image of up-titration.

Delta Sleep Inducing Peptide, a nonapeptide first isolated from rabbit brain. Studied for its effects on slow-wave (delta) sleep architecture and stress modulation. Limited modern clinical data.

Estimated Glomerular Filtration Rate. A calculated measure of kidney filtration capacity using creatinine, age, and sex. The primary metric for staging kidney function.

The clinical name for SS-31, a synthetic tetrapeptide that selectively concentrates in the inner mitochondrial membrane via cardiolipin binding. Studied in primary mitochondrial myopathy, dry age-related macular degeneration, and other mitochondrial-driven conditions.

Produced naturally within the body. Endogenous testosterone is the testosterone the body makes; exogenous testosterone is what is administered.

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied by Russian researchers for telomerase activation and pineal-axis effects. Also spelled Epithalon. Among the most-discussed compounds in longevity-oriented peptide circles.

The primary estrogen in non-pregnant adults. Critical in both sexes for bone density, cognitive function, lipid metabolism, and tissue maintenance. Optimal levels are sex-specific and age-specific.

A secondary estrogen, predominant after menopause. Produced in adipose tissue from androgen precursors. Pairs with E2 in a complete estrogen panel.

The weakest of the three primary estrogens. Dominant during pregnancy. Limited diagnostic role outside of obstetric contexts.

Originating outside the body. Administered hormones, peptides, and drugs are all exogenous. The opposite of endogenous.

Serum glucose measured after an overnight fast. The classic screen for hyperglycemia and diabetes. Less sensitive than fasting insulin or HOMA-IR for early metabolic dysfunction.

Serum insulin measured after an overnight fast. A direct readout of metabolic state. Often more sensitive than fasting glucose for detecting early insulin resistance.

The body's primary iron storage protein. Low ferritin indicates iron deficiency. High ferritin can indicate iron overload or inflammation, since ferritin is also an acute-phase reactant.

A 15-amino-acid peptide derived from the neural cell adhesion molecule (NCAM). Studied in animal models for cognitive enhancement and neuroprotection. Limited clinical data.

The plastic tear-off cover protecting the rubber stopper of a vial before first use. Removed once and discarded. Does not maintain sterility once removed.

Vitamin B9. A cofactor in methylation, DNA synthesis, and red blood cell formation. Frequently paired with B12 in panels because deficiency presentations overlap.

A protein that binds and inhibits myostatin, a negative regulator of skeletal muscle mass. Follistatin-based research compounds explore muscle hypertrophy without androgen receptor activation.

A modified peptide designed to disrupt the FOXO4 to p53 interaction in senescent cells, theorized to selectively trigger apoptosis in those cells (a "senolytic" mechanism). Early-stage research compound.

The unbound, biologically active form of triiodothyronine, the primary metabolic thyroid hormone. A more accurate readout of thyroid function at the tissue level than TSH alone.

The unbound form of thyroxine, the storage thyroid hormone that is converted to T3 in peripheral tissues. Reads the upstream thyroid output before peripheral conversion.

The unbound, bioavailable fraction of total testosterone. Approximately 1 to 3% of total testosterone. Directly correlates with androgen receptor activation in tissues.

The fraction of IGF-1 not bound to IGFBP-3 or other binding proteins. Considered a more direct measure of bioactive IGF-1 than total IGF-1, though less commonly available.

Follicle Stimulating Hormone. A pituitary gonadotropin that drives gametogenesis in both sexes. Paired with LH for evaluating reproductive axis function.

Gamma-Glutamyl Transferase. A liver enzyme particularly sensitive to alcohol use and bile duct disease. Often the earliest liver enzyme to rise with chronic alcohol exposure.

Any compound that stimulates the pituitary to release growth hormone. Includes GHRH analogs (CJC-1295, Sermorelin, Tesamorelin) and ghrelin mimetics (Ipamorelin, GHRP-2, GHRP-6, Hexarelin).

Glycyl-L-Histidyl-L-Lysine, a tripeptide that occurs naturally in human plasma and declines with age. Studied for tissue remodeling, gene expression modulation, and skin regeneration.

GHK bound to a copper ion. The copper complex is the form most studied in tissue repair, hair follicle stimulation, and dermatologic research. Frequently used in topical and injectable research formulations.

A peptide hormone produced primarily in the stomach. Stimulates appetite and triggers GH release via the ghrelin receptor (GHS-R). The endogenous target mimicked by GHRPs and ipamorelin.

Growth Hormone Releasing Hormone. The hypothalamic peptide that drives pituitary GH release. The endogenous target of CJC-1295, Sermorelin, and Tesamorelin (all GHRH analogs).

Growth Hormone Releasing Peptide 2, a ghrelin mimetic that stimulates pituitary GH release. Slightly more potent than Ipamorelin but with measurably more cortisol and prolactin spillover.

Growth Hormone Releasing Peptide 6. Notable for producing strong appetite stimulation alongside GH release. Less specific than Ipamorelin; more side-effect potential.

Glucagon-Like Peptide-1 receptor agonists. A class of pharmaceuticals indicated for type 2 diabetes and chronic weight management. Mentioned here for terminology completeness only; THE PIVOTAL PROTOCOL does not provide medical guidance on these prescription medications.

The rate at which the body clears glucose from circulation, primarily into skeletal muscle and adipose tissue. A direct functional readout of insulin sensitivity.

Gonadotropin Releasing Hormone. The hypothalamic peptide that drives pituitary release of LH and FSH. The upstream signal of the entire reproductive axis.

G-Protein Coupled Receptor. A large class of seven-transmembrane receptors that activate intracellular G-proteins on ligand binding. The ghrelin receptor and many peptide hormone receptors are GPCRs.

The time required for the plasma concentration of a compound to fall to half its initial value. Determines dosing frequency, accumulation potential, and washout time. Foundational pharmacokinetic concept.

Glycated Hemoglobin A1c. Reflects average plasma glucose over the prior 8 to 12 weeks. The standard long-term glucose marker.

Human Chorionic Gonadotropin. Mimics LH at the testicular receptor, stimulating endogenous testosterone production. Used as a reproductive axis tool in clinical contexts.

High-Density Lipoprotein. The cholesterol carrier traditionally called "good cholesterol" because it participates in reverse cholesterol transport. Higher functional HDL is associated with lower cardiovascular risk.

A synthetic hexapeptide ghrelin mimetic, structurally related to GHRP-6. The most potent of the GHRP family but also the most prone to receptor downregulation with prolonged use.

Human Menopausal Gonadotropin. A clinical preparation containing both LH and FSH activity. Used in fertility contexts.

Homeostatic Model Assessment of Insulin Resistance. A calculated index using fasting glucose and fasting insulin. Values below 1.0 are excellent, above 2.5 suggest significant insulin resistance.

An amino acid intermediate in methionine metabolism. Elevated levels are associated with cardiovascular and cognitive risk. Reduced by adequate B12, folate, and B6.

The biological principle that low-dose stressors produce adaptive benefits, while high doses cause harm. The basis for exercise, fasting, cold exposure, and many longevity interventions.

Hypothalamic-Pituitary-Adrenal axis. The neuroendocrine system controlling cortisol production via CRH, ACTH, and adrenal cortex. The central stress response circuit.

Hypothalamic-Pituitary-Gonadal axis. The reproductive axis, controlling sex hormone production via GnRH, LH, FSH, and gonadal output.

Hypothalamic-Pituitary-Thyroid axis. The neuroendocrine system controlling thyroid hormone production via TRH, TSH, and thyroid output.

High-sensitivity C-Reactive Protein. The same molecule as standard CRP but measured with greater precision at low concentrations. The preferred marker for chronic, low-grade systemic inflammation.

A 24-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 16S rRNA gene. Studied for cytoprotective and metabolic signaling effects. Part of the broader MDP (mitochondrial-derived peptide) family alongside MOTS-c.

Insulin-like Growth Factor 1, the primary downstream mediator of growth hormone action. Produced largely by the liver in response to GH. Serves as the standard biomarker for GH-axis activity because direct GH measurement is pulsatile and unreliable.

A modified IGF-1 analog (Long R3 IGF-1) with reduced binding affinity for IGF binding proteins, extending its plasma half-life from minutes to hours. A research-only compound used in cell culture and animal studies.

A truncated IGF-1 analog (DES(1-3) IGF-1) lacking the first three amino acids, which dramatically reduces binding protein affinity. Research-only compound.

Insulin-like Growth Factor Binding Protein 3. The primary carrier of circulating IGF-1, modulating its bioavailability. The IGF-1 to IGFBP-3 ratio gives a more complete picture of GH-axis status than IGF-1 alone.

Interleukin 6. A pro-inflammatory cytokine that also has paradoxical anti-inflammatory roles in acute exercise. Elevated chronic IL-6 is a marker of systemic inflammation.

Interleukin 10. A primary anti-inflammatory cytokine. Often used in research as a counterbalance metric to pro-inflammatory IL-6 and TNF-alpha.

The phenomenon whereby oral glucose triggers a far greater insulin response than the same amount of glucose given intravenously. Mediated by gut hormones including GLP-1 and GIP. The basis of the GLP-1 receptor agonist drug class.

Acute inflammation is the short-lived adaptive response to injury or infection. Chronic inflammation is sustained low-grade activation that drives disease over years. Different mechanisms, different metrics, different interventions.

The state in which tissues require more insulin than normal to clear glucose. The earliest detectable defect in metabolic dysfunction. Reversible with diet, exercise, and weight loss in most cases.

The opposite of insulin resistance. The efficiency with which insulin clears glucose from circulation. Higher sensitivity equals lower insulin requirement for the same glucose load.

A small-volume syringe (typically 0.3 mL or 0.5 mL) marked in insulin units rather than milliliters. The standard delivery instrument for subcutaneous peptide injection because of its short, fine needle and precise unit-graduated barrel.

An injection delivered directly into muscle tissue. Faster absorption than subcutaneous but generally not used in peptide protocols, which favor the slow, steady release of subcutaneous delivery.

A molecule that binds a receptor and produces the opposite effect of an agonist by suppressing constitutive (basal) receptor activity. Mechanistically distinct from a simple antagonist.

A selective ghrelin receptor agonist that stimulates pituitary GH release with minimal cortisol or prolactin spillover. Considered the cleanest of the GHRP family and the most common partner for CJC-1295 in pulse-style protocols.

The acetate salt form of Ipamorelin, the standard research-grade form. Refers to how the peptide is paired with an acidic counterion to stabilize the lyophilized form.

Serum iron. Reflects iron in transit, not iron stores. Should be interpreted alongside ferritin, TIBC, and transferrin saturation, not in isolation.

A peptide that stimulates gonadotropin-releasing hormone (GnRH) at the hypothalamic level, upstream of LH and FSH. Studied as a tool for evaluating reproductive axis function and for fertility research.

Low-Density Lipoprotein cholesterol. The primary atherogenic lipoprotein on standard panels. Increasingly considered a coarser metric than Apo-B for risk assessment.

A satiety hormone produced by adipose tissue. Signals energy stores to the hypothalamus. Leptin resistance, where high circulating leptin fails to suppress appetite, is a feature of obesity.

Any molecule that binds to a receptor or other binding site. Ligands can be agonists, antagonists, partial agonists, or inverse agonists depending on the consequence of binding.

Luteinizing Hormone. A pituitary gonadotropin driving testosterone production in males and ovulation in females. Paired with FSH for reproductive axis evaluation.

A standard blood test measuring Total Cholesterol, LDL-C, HDL-C, and Triglycerides. The legacy cardiovascular risk tool. Increasingly supplemented or replaced by Apo-B and Lp(a) for sharper risk assessment.

A GLP-1 receptor agonist available by prescription. Listed for terminology completeness only; THE PIVOTAL PROTOCOL does not provide medical guidance on prescription medications.

An initial higher-than-maintenance dose used to reach steady-state plasma concentration faster. Common when half-life is long and steady-state would otherwise take weeks.

Lipoprotein(a). An LDL-like particle with an additional apolipoprotein(a) tail. Largely genetically determined. Independent and additive cardiovascular risk factor not addressed by lifestyle or most lipid-lowering therapy.

Freeze-dried. The state in which most research peptides are shipped, because removing water dramatically extends shelf life. Lyophilized peptides require reconstitution before use.

A sealed glass vial containing freeze-dried peptide powder under partial vacuum. The primary container format for research peptides.

An essential mineral involved in over 300 enzymatic reactions, including ATP production. Serum magnesium underestimates total body status because most magnesium is intracellular.

The dose given on a regular schedule to maintain steady-state plasma concentration after a loading dose, or simply the standing dose if no loading is used.

An early synthetic alpha-MSH analog studied for melanin production. Less commonly used than Melanotan II in current research discussions.

A synthetic analog of alpha-melanocyte-stimulating hormone studied for melanin production and incidentally for sexual response. The parent compound that led to the development of Bremelanotide (PT-141).

A post-translational modification (also a DNA modification) in which a methyl group is added. Regulates gene expression, protein function, and detoxification pathways.

A metabolite that accumulates when B12 is deficient at the cellular level. More sensitive than serum B12 for detecting functional B12 deficiency.

A subtherapeutic dose used either to probe response or to provide minimal stimulation while avoiding receptor downregulation. A common tool in cycle design.

Mechano Growth Factor, a splice variant of IGF-1 produced locally in muscle in response to mechanical loading. Studied for its role in satellite cell activation and muscle hypertrophy.

The process by which cells generate new mitochondria. Triggered by exercise, caloric restriction, cold exposure, and certain peptides (notably MOTS-c). Central to discussions of cellular energy and aging.

Selective autophagy of damaged mitochondria. The cellular quality control mechanism that maintains a healthy mitochondrial pool. Declines with age.

A 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene. Studied for metabolic regulation, exercise mimicry, and AMPK pathway activation. Levels decline with age. See Module 8

Mechanistic Target of Rapamycin. A central kinase that integrates nutrient and growth signals to regulate cell growth, protein synthesis, and autophagy. The mTOR-autophagy balance is foundational in longevity research.

A vial intended for multiple withdrawals across days or weeks, requiring a preserved diluent (bacteriostatic water) and disciplined sterile technique on every entry.

The condition in which multiple compound or lifestyle changes happen simultaneously, making it impossible to attribute outcome to any single variable. The opposite of single-variable testing.

N-acetylated Selank. A modified form of Selank with an acetyl group at the N-terminus, intended to improve oral and intranasal stability. Research-grade compound.

N-acetylated Semax. The acetylated variant of Semax, modified for enhanced stability and duration of action.

Nicotinamide Adenine Dinucleotide, a coenzyme central to redox reactions, mitochondrial energy production, and sirtuin activity. NAD+ levels decline with age, motivating research on precursors like NMN and NR.

A standardized measure of needle thickness. Higher gauge numbers indicate thinner needles. Common subcutaneous gauges in peptide protocols include 27g, 28g, 29g, 30g, and 31g.

The shaft length of a needle, typically expressed in inches. Subcutaneous insulin syringes commonly use 5/16 inch (8 mm) or 1/2 inch (12.7 mm) needles.

Nuclear Factor kappa B. A transcription factor pathway central to inflammation, immune response, and cell survival. Persistently activated NF-kB drives chronic inflammatory disease.

A multi-protein complex that activates the inflammatory cytokine IL-1-beta in response to cellular danger signals. A target of growing interest in age-related inflammation research.

The portion of a cycling protocol in which no compound is administered. Allows receptor recovery, lab cleanup, and physiologic recalibration before the next cycle.

Oral Glucose Tolerance Test. A timed measurement of glucose (and often insulin) following a 75-gram glucose challenge. Catches metabolic dysfunction missed by fasting glucose.

The state in which reactive oxygen species production exceeds antioxidant defense capacity. Drives mitochondrial damage, protein dysfunction, and DNA damage. Central to aging biology.

A small peptidomimetic derived from a region of ciliary neurotrophic factor. Studied in animal models for memory and neurogenesis. Distinct from the cell-cycle inhibitor protein also called p21.

An aminopropyl carbazole compound (not a peptide) studied for neuroprotective effects via NAMPT activation. Often discussed in the same neuroregenerative research conversations as Cerebrolysin.

A protocol used after compounds that suppress endogenous hormone production, designed to restore baseline. More commonly discussed in androgen contexts than in peptide cycle design.

A ligand that activates a receptor but produces less than maximal response even at saturating concentration. Useful when full agonism causes downregulation.

A peptide composed of 15 amino acids. BPC-157 is the canonical example; the term is sometimes used as a synonym in research literature.

What the body does to a compound: absorption, distribution, metabolism, excretion. Half-life, Cmax, Tmax, and AUC are all pharmacokinetic measures.

What a compound does to the body: the relationship between concentration and biological effect. The mechanism-of-action complement to pharmacokinetics.

Serum phosphorus. Tightly regulated by the kidneys and parathyroid hormone. Abnormalities are uncommon in healthy adults but flag kidney or endocrine issues when present.

A post-translational modification in which a phosphate group is added to a protein, typically activating or deactivating it. The basic switch mechanism for most signaling cascades.

A central growth and survival signaling pathway downstream of insulin and IGF-1. Drives protein synthesis, cell growth, and inhibits autophagy. Heavily studied in both cancer and longevity research.

A synthetic tripeptide (Glu-Asp-Arg) derived from pineal gland research, studied alongside Epitalon for purported neuroprotective and antioxidant effects.

The point in a protocol at which further dosing produces no additional benefit. Triggers a re-evaluation of dose, compound, or cycle structure.

The capacity of a stem cell to differentiate into any of the three primary germ layers, and therefore most cell types. Embryonic stem cells are the prototype; induced pluripotent stem cells are the engineered counterpart.

Any chemical modification of a protein after it has been synthesized. Includes phosphorylation, acetylation, methylation, ubiquitination, glycosylation, and many others.

Serum potassium. The primary intracellular cation. Tight regulation is essential for cardiac and neuromuscular function. Both deficiency and excess are clinically dangerous.

A precursor steroid synthesized from cholesterol, upstream of all other steroid hormones. Sometimes called the "mother hormone." Levels decline with age.

A steroid hormone central to the female reproductive cycle and pregnancy. Also produced in smaller amounts in males with neurosteroid roles.

A pituitary hormone primarily known for lactation. Elevated prolactin suppresses GnRH and disrupts the reproductive axis in both sexes.

A dosing pattern designed to produce sharp, short-duration peaks in plasma concentration that mimic natural pulsatile hormone release. The opposite of continuous dosing.

Two contrasting GH release patterns. A "pulse" mimics natural physiology with sharp, time-bound spikes (achieved by short-acting agents). A "bleed" produces sustained elevation (achieved by long-acting agents like CJC-1295 DAC). Different goals, different trade-offs.

The number of functional receptors expressed on a cell surface. Increases (upregulation) and decreases (downregulation) in response to ligand exposure, gene expression changes, and signaling crosstalk.

The cellular adaptation whereby chronic exposure to a ligand reduces the number or sensitivity of its receptors. The biological reason cycling and washout periods exist in well-designed protocols.

How responsive a receptor is to a given ligand concentration. Functionally distinct from receptor density. Both can drive a clinical response without the other changing.

A class of single-pass membrane receptors that phosphorylate tyrosine residues on themselves and downstream targets when activated. Includes the IGF-1 receptor and insulin receptor.

The process of dissolving a lyophilized peptide in bacteriostatic water to create an injectable solution. Requires correct volume calculation, sterile technique, and proper dose math. See Module 3

The standard storage temperature for reconstituted peptides. Lyophilized peptides typically tolerate room temperature for shipping windows but are returned to refrigeration on receipt.

A dedicated washout window designed not just for tapering but for full physiologic and receptor recalibration before a new protocol begins.

Outcome data gathered during and after a cycle, including labs, body composition, subjective markers, and performance metrics. The other half of the equation alongside baseline data.

An investigational triple agonist (GLP-1, GIP, glucagon receptors) studied in clinical trials for obesity and metabolic disease. Listed for terminology completeness.

An inactive isomer of T3 produced when peripheral conversion shunts T4 down a non-productive pathway. Elevated in chronic illness, severe stress, and prolonged caloric restriction. Useful adjunct to Free T3 and Free T4.

Reactive Oxygen Species. Highly reactive oxygen-containing molecules including superoxide and hydrogen peroxide. Produced by mitochondria and immune cells; both signaling molecules and damage agents at different levels.

A synthetic heptapeptide derived from tuftsin, developed in Russia. Studied for anxiolytic and immunomodulatory effects via GABAergic and BDNF-related pathways. Often paired conceptually with Semax in cognition research discussions.

A synthetic heptapeptide based on a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. Studied for nootropic and neuroprotective effects via BDNF upregulation. Used clinically in Russia for stroke recovery research.

A GLP-1 receptor agonist available by prescription. Listed for terminology completeness only; THE PIVOTAL PROTOCOL does not provide medical guidance on prescription medications.

A cellular state of permanent growth arrest in which cells stop dividing but remain metabolically active, often secreting inflammatory factors. Accumulates with age and drives "inflammaging."

A compound that selectively triggers cell death in senescent cells while sparing healthy ones. An active area of longevity research. FOXO4-DRI is one peptide example.

A 29-amino-acid GHRH analog (the first 29 residues of native GHRH). The original FDA-approved GHRH analog. Stimulates pituitary GH release in a physiologically pulsatile manner.

Sex Hormone Binding Globulin. The primary serum carrier of testosterone and estradiol. SHBG-bound hormone is biologically unavailable. Required to interpret total testosterone in context.

A puncture-resistant disposal container for used needles and syringes. Required practice for any injection protocol. Available at pharmacies; many municipalities accept full containers as hazardous waste.

A vial intended for one withdrawal and immediate disposal of remaining contents. Often used with sterile water for injection (SWFI) in clinical contexts.

The discipline of changing exactly one input at a time so that any observed outcome can be attributed to that change. The foundation of meaningful protocol data.

A family of NAD+-dependent deacetylase enzymes (SIRT1 through SIRT7) involved in metabolic regulation, DNA repair, and longevity signaling. Heavily studied in caloric restriction and aging contexts.

Serum sodium. The primary extracellular cation. Critical for fluid balance and neurological function. Disturbances are usually water-balance issues, not salt-intake issues.

A synthetic mitochondrial-targeted tetrapeptide (also called Elamipretide and Bendavia) that selectively binds cardiolipin in the inner mitochondrial membrane. Studied in primary mitochondrial myopathy and other mitochondrial-driven conditions.

A combination of two or more compounds used together with the goal of complementary or synergistic effect. The opposite of single-variable testing. Stacks reduce data quality but can amplify outcome.

The practice of cycling between different stacks across the year to vary stimulus, prevent tachyphylaxis, and probe different physiological systems.

The act of combining compounds within a single cycle. Done deliberately to capture synergy, accidentally to compound confound. Discipline distinguishes the two.

Undifferentiated cells with the capacity for self-renewal and differentiation into specialized cell types. Foundation of regenerative biology research.

Preservative-free sterile water used for single-use reconstitution. Without preservative, the reconstituted solution must be used immediately. Distinct from bacteriostatic water.

The rubber septum on a vial sealed under an aluminum crimp cap. The needle pierces the stopper for reconstitution and dose withdrawal. Wipe with alcohol before each puncture.

An injection delivered into the fat layer just beneath the skin. The default route for most peptide protocols because of its slow, predictable absorption and low complication rate.

An investigational dual agonist (GLP-1 and glucagon receptors) in clinical trials for obesity and metabolic disease. Listed for terminology completeness.

The principle that two compounds together produce an effect greater than the sum of their individual effects. The most cited (and most overstated) justification for stacks. True synergy requires evidence, not assumption.

The rapid loss of response to a compound after repeated administration. Often driven by receptor downregulation. The pharmacological reason cycling exists.

A planned, gradual reduction of dose at the end of a cycle, used to ease the transition off a compound and minimize rebound effects.

A synthetic peptide fragment of Thymosin Beta-4. Studied for tissue repair, angiogenesis, and inflammation modulation. Frequently paired with BPC-157 in recovery research discussions.

Repetitive DNA sequences capping the ends of chromosomes. Shorten with each cell division. Telomere length is a biomarker of cellular age and a focus of longevity research.

The enzyme that adds telomere repeat sequences to chromosome ends, counteracting telomere shortening. Active in stem cells and germ cells; largely silent in most somatic tissue.

A stabilized GHRH analog approved for HIV-associated lipodystrophy. Notable as the only GHRH analog with FDA approval for a specific indication. Studied off-label for visceral adiposity and cognitive endpoints in older adults.

Thyroglobulin antibodies. Autoantibodies against the thyroid storage protein. Paired with TPO antibodies for diagnosis of autoimmune thyroid disease.

Transforming Growth Factor beta. A cytokine family central to tissue remodeling, immune regulation, and fibrosis. Both protective and pathologic depending on context.

A polypeptide preparation extracted from thymic tissue, studied primarily by Russian researchers for immunomodulation and longevity. Less characterized than Thymosin Alpha-1 in Western literature.

A 28-amino-acid peptide naturally produced by the thymus gland. Approved in over 30 countries (not the United States) for hepatitis B, hepatitis C, and immune support during chemotherapy. Modulates T-cell function.

The native 43-amino-acid actin-sequestering peptide from which TB-500 is derived. Involved in cell migration, wound healing, and angiogenesis.

Total Iron Binding Capacity. The maximum amount of iron the blood proteins can bind. Used with serum iron and ferritin for full iron status assessment.

A dual GLP-1 and GIP receptor agonist available by prescription. Listed for terminology completeness only; THE PIVOTAL PROTOCOL does not provide medical guidance on prescription medications.

The time after dosing at which plasma concentration reaches its peak (Cmax). Together with Cmax and AUC, characterizes how rapidly and how high a compound rises in circulation.

Tumor Necrosis Factor alpha. A pro-inflammatory cytokine central to acute immune response and chronic inflammatory disease. Targeted by several biologic medications.

A breakdown product of heme metabolism. Elevations can indicate liver dysfunction, biliary obstruction, or hemolysis. Often paired with direct (conjugated) bilirubin for differentiation.

The sum of free and binding-protein-bound IGF-1 in serum. The standard clinical measure of GH-axis activity, since GH itself is too pulsatile to measure usefully on a single draw.

Sum of albumin and globulins in serum. A coarse measure of overall protein synthesis, kidney loss, and immune activation. Useful as a screening number; never diagnostic alone.

The sum of all testosterone in serum, both protein-bound and free. The first-pass screening number. Useless on its own without SHBG and Free Testosterone for full interpretation.

Thyroid Peroxidase antibodies. Autoantibodies against the enzyme that catalyzes thyroid hormone synthesis. The primary serologic marker of Hashimoto's thyroiditis.

The cellular process of copying a DNA sequence into messenger RNA. The first step of gene expression. Regulated by transcription factors and chromatin state.

The percentage of transferrin (the iron transport protein) currently bound to iron. Calculated from serum iron divided by TIBC. A core iron-status metric.

The cellular process of synthesizing a protein from messenger RNA at the ribosome. The second step of gene expression after transcription.

A class of lipid molecules consisting of three fatty acids on a glycerol backbone. Elevated triglycerides flag insulin resistance, alcohol exposure, or genetic dyslipidemia.

Thyroid Stimulating Hormone. The pituitary signal that drives thyroid output. The standard first-line thyroid screening test, but inadequate alone; pair with Free T3, Free T4, and Reverse T3 for a complete view.

An insulin syringe calibration where 100 units equals 1 mL. The most common syringe used in peptide protocols. One unit equals 0.01 mL.

A less common insulin syringe calibration where 50 units equals 0.5 mL. Same volume per unit as U-100; the difference is total syringe capacity.

A small-volume insulin syringe (typically 0.3 mL total capacity) marked in 30 units. Common for very small doses where graduation precision matters.

A planned increase of dose over time, typically used to find the minimum effective dose or to allow physiologic adaptation before reaching target dose.

Vascular Endothelial Growth Factor. The primary signal for angiogenesis (new blood vessel formation). Frequently cited as a downstream mechanism for BPC-157 and TB-500 tissue repair effects.

The small glass container holding lyophilized peptide. Sealed with a rubber stopper and an aluminum crimp. Standard sizes are 2 mL and 3 mL for peptide research material.

Cobalamin. Required for red blood cell formation, neurologic function, and methylation. Serum B12 misses functional deficiency that methylmalonic acid can catch.

25-hydroxyvitamin D, the storage form measured in serum. The standard biomarker for vitamin D status. Functional ranges typically target 50 to 80 ng/mL, well above the deficiency cutoff.

1,25-dihydroxyvitamin D (calcitriol), the active hormonal form. Tightly regulated and not used for routine vitamin D status; reserved for specific clinical questions involving calcium metabolism.

A defined window between cycles in which no compound is used. Allows receptor recovery, hormonal recalibration, and clean baseline lab work. Essential for separating signal from confound across cycles.

A common needle thickness for thicker reconstituted solutions. The thickest of the standard subcutaneous gauges discussed here.

A general-purpose subcutaneous gauge balancing draw speed and injection comfort.

A common needle thickness for insulin syringes used in subcutaneous peptide injection. Slightly thicker than 31G. Easier to draw thicker reconstituted solutions.

A finer subcutaneous gauge often available in pre-attached insulin syringes. Common for daily-use protocols.

A finer needle thickness offering reduced injection sensation. Excellent for thin solutions and frequent injection protocols. Slightly slower to draw than 29G.

An 8 mm needle length. The standard short subcutaneous needle. Adequate for most adults injecting into abdomen or thigh fat.

A 12.7 mm needle length. Used when a deeper subcutaneous injection is preferred. Less common for standard peptide protocols than the 5/16 inch.